Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Arrhythmic Effects Evaluated on Caenorhabditis elegans, The Case of Polypyrrole Nanoparticles

  • Srinivasan, Sumithra Yasaswini|||0000-0002-0473-9801
  • Illera, Pilar Alvarez
  • Kukhtar, Dmytro
  • Benseny Cases, Núria|||0000-0003-4603-6829
  • Cerón, Julián|||0000-0003-4739-2243
  • Álvarez, Javier
  • Fonteriz, Rosalba I.
  • Montero, Mayte
  • Laromaine, Anna|||0000-0002-4764-0780
Experimental studies and clinical trials of nanoparticles for treating diseases are increasing continuously. However, the reach to the market does not correlate with these efforts due to the enormous cost, several years of development, and off-target effects like cardiotoxicity. Multicellular organisms such as the Caenorhabditis elegans (C. elegans) can bridge the gap between in vitro and vertebrate testing as they can provide extensive information on systemic toxicity and specific harmful effects through facile experimentation following 3R EU directives on animal use. Since the nematodes' pharynx shares similarities with the human heart, we assessed the general and pharyngeal effects of drugs and polypyrrole nanoparticles (Ppy NPs) using C. elegans. The evaluation of FDA-approved drugs, such as Propranolol and Racepinephrine reproduced the arrhythmic behavior reported in humans and supported the use of this small animal model. Consequently, Ppy NPs were evaluated due to their research interest in cardiac arrhythmia treatments. The NPs' biocompatibility was confirmed by assessing survival, growth and development, reproduction, and transgenerational toxicity in C. elegans. Interestingly, the NPs increased the pharyngeal pumping rate of C. elegans in two slow-pumping mutant strains, JD21 and DA464. Moreover, the NPs increased the pumping rate over time, which sustained up to a day post-excretion. By measuring pharyngeal calcium levels, we found that the impact of Ppy NPs on the pumping rate could be mediated through calcium signaling. Thus, evaluating arrhythmic effects in C. elegans offers a simple system to test drugs and nanoparticles, as elucidated through Ppy NPs.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NextGEM: Next-Generation Integrated Sensing and Analytical System for Monitoring and Assessing Radiofrequency Electromagnetic Field Exposure and Health

  • Petroulakis, Nikolaos
  • Mattsson, Mats-Olof
  • Chatziadam, Panos
  • Simko, Myrtill
  • Gavrielides, Andreas
  • Yiorkas, Andrianos M.
  • Zeni, Olga
  • Scarfi, Maria Rosaria
  • Soudah, Eduardo
  • Otin, Ruben
  • Schettino, Fulvio
  • Migliore, Marco Donald
  • Miaoudakis, Andreas
  • Spanoudakis, George
  • Bolte, John
  • Korkmaz, Erdal
  • Theodorou, Vasileios
  • Zarogianni, Eleni
  • Lagorio, Susanna
  • Biffoni, Mauro
  • Schiavoni, Andrea
  • Boldi, Mauro Renato
  • Feldman, Yuri
  • Bilik, Igal
  • Laromaine, Anna
  • Gich, Martí
  • Spirito, Marco
  • Ledent, Maryse
  • Segers, Seppe
  • Vargas, Francisco
  • Colussi, Loek
  • Pruppers, Mathieu
  • Baaken, Dan
  • Bogdanova, Anna
The evolution of emerging technologies that use Radio Frequency Electromagnetic Field (RF-EMF) has increased the interest of the scientific community and society regarding the possible adverse effects on human health and the environment. This article provides NextGEM’s vision to assure safety for EU citizens when employing existing and future EMF-based telecommunication technologies. This is accomplished by generating relevant knowledge that ascertains appropriate prevention and control/actuation actions regarding RF-EMF exposure in residential, public, and occupational settings. Fulfilling this vision, NextGEM commits to the need for a healthy living and working environment under safe RF-EMF exposure conditions that can be trusted by people and be in line with the regulations and laws developed by public authorities. NextGEM provides a framework for generating health-relevant scientific knowledge and data on new scenarios of exposure to RF-EMF in multiple frequency bands and developing and validating tools for evidence-based risk assessment. Finally, NextGEM’s Innovation and Knowledge Hub (NIKH) will offer a standardized way for European regulatory authorities and the scientific community to store and assess project outcomes and provide access to findable, accessible, interoperable, and reusable (FAIR) data., This work is part of the European Union’s Horizon Europe research and innovation program under grant agreement No. 101057527 (NextGEM). Funded by the European Union. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. ICMAB-CSIC and CIMNE have also been partially supported by the Spanish Ministry of Science and Innovation, through the Severo Ochoa Programme for Centres of Excellence in R&D (CEX2019–000917-S) and (CEX2018-000797-S), respectively., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (referencia del instituto). Por ejemplo: With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019–000917-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (referencia del instituto). Por ejemplo: With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2018-000797-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Arrhythmic Effects Evaluated on Caenorhabditis elegans: The Case of Polypyrrole Nanoparticles

  • Srinivasan, Sumithra Y.
  • Alvarez-Illera, Pilar
  • Kukhtar, Dmytro
  • Benseny-Cases, Núria
  • Cerón, Julián
  • Álvarez. Javier
  • Fonteriz, Rosalba I.
  • Montero, Mayte
  • Laromaine, Anna
Experimental studies and clinical trials of nanoparticles for treating diseases are increasing continuously. However, the reach to the market does not correlate with these efforts due to the enormous cost, several years of development, and off-target effects like cardiotoxicity. Multicellular organisms such as the Caenorhabditis elegans (C. elegans) can bridge the gap between in vitro and vertebrate testing as they can provide extensive information on systemic toxicity and specific harmful effects through facile experimentation following 3R EU directives on animal use. Since the nematodes’ pharynx shares similarities with the human heart, we assessed the general and pharyngeal effects of drugs and polypyrrole nanoparticles (Ppy NPs) using C. elegans. The evaluation of FDA-approved drugs, such as Propranolol and Racepinephrine reproduced the arrhythmic behavior reported in humans and supported the use of this small animal model. Consequently, Ppy NPs were evaluated due to their research interest in cardiac arrhythmia treatments. The NPs’ biocompatibility was confirmed by assessing survival, growth and development, reproduction, and transgenerational toxicity in C. elegans. Interestingly, the NPs increased the pharyngeal pumping rate of C. elegans in two slow-pumping mutant strains, JD21 and DA464. Moreover, the NPs increased the pumping rate over time, which sustained up to a day post-excretion. By measuring pharyngeal calcium levels, we found that the impact of Ppy NPs on the pumping rate could be mediated through calcium signaling. Thus, evaluating arrhythmic effects in C. elegans offers a simple system to test drugs and nanoparticles, as elucidated through Ppy NPs., This work was supported by the Ministry of Science and Innovation (MICINN) “Severo Ochoa” program for centers of excellence through the BEAT project (FUNFUTURE-FIP-2020), MICINN project PID2021-122239OB-I00 and partly supported by the European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). Funded by the European Union. Some experiments were performed at MIRAS beamline at ALBA Synchrotron with the collaboration of ALBA staff. SYS is enrolled in the Materials Science Ph.D. program of Universitat Autonoma de Barcelona (UAB). SYS acknowledges financial support from DOC-FAM, European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 754397. AL and SYS participate in the networks of EPNOE, Red Nanocare2.0 , and the CSIC Interdisciplinary Platform for Sustainable Plastics toward a Circular Economy, SUSPLAST. The authors acknowledge the use of Biorender.com, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

WorMe: A user-oriented software for Caenorhabditis elegans length determination

  • Llobet Lladó, Josep
  • Garriga Alonso, Núria
  • Muñoz Juan, Amanda
  • Laromaine, Anna
Version v2.18.1, Caenorhabditis elegans is a widely used animal model for biomedical research. The length of the nematode is a quantifiable parameter commonly used to assess its development and evaluate its health. Although most measurements are performed manually, software that automates this process exists. However, most available tools are designed for stereomicroscope images, and none work reliably for optical microscopy images. Here, we present WorMe, a user-friendly software that measures C. elegans length in optical microscopy images. The program is versatile in handling various image types, and can analyse multiple images collectively. Furthermore, the user can accept or discard the detected objects, separate joined worms, correct erroneous measurements, and manually add new worms. Then, the length results are presented in a spreadsheet file, with each measurement linked to its image. Graphic data can also be exported., The work has been supported partially with RTI2018-096273-B100, PID2021-122645OB-100 funded by MCIN/AEI//10.13039/501100011033/FEDER “Una manera de hacer Europa”; the “Severo Ochoa” Programme for Centres of Excellence, in R&D CEX2019-000917-S (FUNFUTURE), CEX2023-001263-S (MATRANS42), and European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). JLL acknowledges ayudas JAE ICU, Consejo Superior de Investigaciones Científicas (CSIC), JAEICU-21-ICMAB01 (2021) in the framework of the Master of Bioinformatics and Biostatistics (UOC, 2021), NGA acknowledges ayudas JAEIntro, Consejo Superior de Investigaciones Científicas (CSIC), JAEINT-24-01745, (2024), AMJ acknowledges the Ph.D. scholarship (FPU18/05190)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

WorMe: A user-oriented software for Caenorhabditis elegans length determination

  • Llobet Lladó, Josep
  • Garriga Alonso, Núria
  • Muñoz Juan, Amanda
  • Laromaine, Anna
Caenorhabditis elegans is a widely used animal model for biomedicl research. The lenght of this nematode is commonly used to asses its evelopment and its health. Typically, measurements are performed manually; however, software has been developed to automate this process. Most of these tools are designed for stereomicroscope images, and none work reliably for compound microscopy images. Here we present WorMe, a user-friendly software that measures C.elegans length in compound microscopy images. The program is versatile in handling various image types and can be analyse multiple images collectively. Funthermore, the user can accept of discard the detected objects, separate joined worms, correct erroneous measurements, and manually add new worms. The length results are presented in a spreadsheet file, with earch measurement linked to its image. Graphic data can also be exported., The work has been supported partially with RTI2018-096273B-I00, PID2024-1576370B-I00 (BACTIVE), PDC2023-145826-I00 (BIOCCHIP), funded by MCIN/AEI//10.13039/501100011033/FEDER “Una manera de hacer Europa”; the “Severo Ochoa” Programme for Centres of Excellence, in R&D CEX2019-000917-S (FUNFUTURE), CEX2023-001263-S (MATRANS42); the Generalitat de Catalunya (2021SGR00446 Grant), and European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). AL participates in CSIC-Conexion Nanomedicina del CSIC, EPNOE network, and Red Nanocare 2.0, Grant RED2022-134560-T funded by MCIN/AEI/10.13039/501100011033, JLL acknowledges ayudas JAE ICU, Consejo Superior de Investigaciones Científicas (CSIC), JAEICU-21-ICMAB01 (2021) in the framework of the Master of Bioinformatics and Biostatistics (UOC, 2021), NGA acknowledges ayudas JAEIntro, Consejo Superior de Investigaciones Científicas (CSIC), JAEINT-24-01745, (2024), AMJ acknowledges the Ph.D. scholarship (FPU18/05190)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S). With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Advances in Conductive Nanomaterials for Cardiac Arrhythmia and Future Directions in Bioevaluation Strategies

  • Srinivasan, Sumithra Y.
  • Laromaine, Anna
Cardiac arrhythmia (CA), characterized by irregular heart rhythms, affects nearly 90% of individuals with cardiovascular diseases. Commonly triggered by myocardial infarction (MI) or ion channel dysfunctions, CA is traditionally treated using pacemakers, cardioversion, ablation, and anti-arrhythmic drugs. Recently, emerging strategies like cardiac patches and injectable formulations with conductive nanomaterials (CNMs) have shown promise in restoring cardiac rhythm post-MI. This review explores CNMs-such as gold nanoparticles, carbon nanotubes, and conjugated polymers-that mimic the electrical and mechanical properties of native cardiac tissue. While in vitro studies show encouraging results, translating CNMs to clinical settings faces challenges. Few studies have assessed their safety and efficacy in rodent models, and none in larger animals. This gap stems from the complexity and ethical hurdles of large animal research. To address this, the review advocates using small animal models like zebrafish, Drosophila melanogaster, and Caenorhabditis elegans. These models offer insights into pharmacokinetics, pharmacodynamics, genetic effects, and cardiac parameters such as ejection fraction and cardiac output-data often unattainable in vitro. Such platforms can better evaluate CNMs' safety and efficacy than 2D/3D cultures, accelerating progress toward clinical application., This work was supported by the Spanish Ministry of Science and Innovation (MICINN) through the National Research Agency (AEI) and European Regional Development Funds (ERDF/FEDER), project BIOSOFT-REGE ref PID2021-122645OB-I00, BACTIVE ref PID2024-1576370B-I00, BIOCCHIP ref PDC2023-145826-I00, the Program/Generalitat de Catalunya (2021SGR00446 project), the Severo Ochoa Program of the Spanish Ministry of Science and Innovation (MICINN_Grant CEX2018−000,789-S, CEX2023-001263-S), and the projects FIP-BEAT, and the PDC2022-133755-I00/AEI/10.13039/501100011033 European Union NextGeneration EU/PRTR. This research was also supported by the European Union's Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, Grant Agreement No. 754397), European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). Authors participate in the Spanish National Research Council (CSIC) interdisciplinary platform for sustainable plastics toward a circular economy (SusPlast), and in CSIC-Conexion Nanomedicina del CSIC, EPNOE network, and Red Nanocare 2.0, Grant RED2022-134560-T funded by MCIN/AEI/10.13039/501100011033. The authors acknowledge the use of Biorender.com., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Assessing Gastrointestinal Motility in Caenorhabditis elegans RAC1/CED-10 Mutants as a Tool to Study Early Parkinson's Disease

  • Muñoz-Juan, Amanda
  • Laromaine, Anna
  • Yuste, Víctor J
  • Dalfó, Esther
Parkinson's disease (PD) is among the most prevalent neurodegenerative disorders and is diagnosed based on motor symptoms that emerge after significant dopaminergic neuron loss. Non-motor symptoms, such as constipation, are the most common and often appear earlier, indicating the onset of the disease. Many animal models are used to study neurodegenerative diseases, yet most focus on the later stages. Because it is difficult to determine the exact start of neurodegeneration, no single model fully represents the entire disease progression. Mammalian models are especially time-consuming and expensive due to their long-life cycles. In contrast, Caenorhabditis elegans (C. elegans), a transparent 1 mm nematode with a short life and reproductive cycle (~3 weeks and 3 days), enables faster, cost-effective experiments thanks to its rapid generation turnover. The defecation motor program in C. elegans consists of rhythmic cycles regulated by a complex genetic network in which Rho/rac GTPases participate, and RAC1 (CED-10 in C. elegans) is among them. We have shown that RAC1/CED-10 mutants exhibit compromised GABAergic morphology and function, which results in disrupted defecation cycles. Here, we present the experimental protocol for measuring constipation in RAC1/CED-10 C. elegans at early stages. In addition to serving as a predictive tool to investigate early PD symptoms prior to neurodegeneration, this protocol could also be employed as an early endpoint to assess the efficacy of pharmacological intervention. Because these changes are not disease-specific, we believe this model provides a valuable tool for investigating alterations that arise early in other illnesses., A.M.J. acknowledges the Ph.D. scholarship (FPU18/05190) in the framework of the Biotechnology Ph.D. at Universitat Autònoma de Barcelona. AL and AMJ acknowledge the funding PID2021-122645OB-100 and PID2024-1576370B-100 by MCIN/AEI//10.13039/501100011033/FEDER "Una manera de hacer Europa"; the "Severo Ochoa" Programme for Centres of Excellence, in R&D CEX2019-000917-S (FUNFUTURE), CEX2023-001263-S (MATRANS42), Generalitat de Catalunya 2021S00446, and European Union's Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). EDC acknowledges support from the APR-2024 grant (PMI24006), funded by the Fundació d'Estudis Superiors en Ciències de la Salut (FESS) and the Fundació Institut de Recerca i Innovació en Ciències de la Vida i la Salut de Catalunya (IRIS-CC)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S). With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

NextGEM: Next-generation integrated sensing and analytical system for monitoring and assessing radiofrequency electromagnetic field exposure and health

  • Petroulakis, Nikolaos
  • Soudah, Eduarto
  • Otín, Rubén
The evolution of emerging technologies that use Radio Frequency Electromagnetic Field (RF-EMF) has increased the interest of the scientific community and society regarding the possible adverse effects on human health and the environment. This article provides NextGEM’s vision to assure safety for EU citizens when employing existing and future EMF-based telecommunication technologies. This is accomplished by generating relevant knowledge that ascertains appropriate prevention and control/actuation actions regarding RF-EMF exposure in residential, public, and occupational settings. Fulfilling this vision, NextGEM commits to the need for a healthy living and working environment under safe RF-EMF exposure conditions that can be trusted by people and be in line with the regulations and laws developed by public authorities. NextGEM provides a framework for generating health-relevant scientific knowledge and data on new scenarios of exposure to RF-EMF in multiple frequency bands and developing and validating tools for evidence-based risk assessment. Finally, NextGEM’s Innovation and Knowledge Hub (NIKH) will offer a standardized way for European regulatory authorities and the scientific community to store and assess project outcomes and provide access to findable, accessible, interoperable, and reusable (FAIR) data., This work is part of the European Union’s Horizon Europe research and innovation program under grant agreement No. 101057527 (NextGEM). Funded by the European Union. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. ICMAB-CSIC and CIMNE have also been partially supported by the Spanish Ministry of Science and Innovation, through the Severo Ochoa Programme for Centres of Excellence in R&D (CEX2019–000917-S) and (CEX2018-000797-S), respectively., Peer Reviewed, Article signat per 34 autors/es: Nikolaos Petroulakis 1,* , Mats-Olof Mattsson 2,* , Panos Chatziadam 1 , Myrtill Simko 2 , Andreas Gavrielides 3 , Andrianos M. Yiorkas 3, Olga Zeni 4 , Maria Rosaria Scarfi 4 , Eduardo Soudah 5 , Ruben Otin 5 , Fulvio Schettino 6 , Marco Donald Migliore 6 , Andreas Miaoudakis 7, George Spanoudakis 7 , John Bolte 8,9 , Erdal Korkmaz 8, Vasileios Theodorou 10 , Eleni Zarogianni 10 , Susanna Lagorio 11 , Mauro Biffoni 11 , Andrea Schiavoni 12 , Mauro Renato Boldi 12, Yuri Feldman 13 , Igal Bilik 13,14 , Anna Laromaine 15 , Martí Gich 15 , Marco Spirito 16, Maryse Ledent 17 , Seppe Segers 17 , Francisco Vargas 18, Loek Colussi 19, Mathieu Pruppers 9, Dan Baaken 20 and Anna Bogdanova 21 1 Institute of Computer Science, Foundation for Research and Technology-Hellas (FORTH-ICS), 70013 Heraklion, Greece 2 SciProof International AB, 83158 Ostersund, Sweden 3 eBOS Technologies Limited, Nicosia 2322, Cyprus 4 Institute for Electromagnetic Sensing of the Environment, Consiglio Nazionale delle Ricerche (CNR-IREA), 80124 Napoli, Italy 5 International Centre for Numerical Methods in Engineering (CIMNE), 08034 Barcelona, Spain 6 Department of Electrical and Computer Science Engineering, University of Cassino and Southern Lazio, 03043 Cassino, Italy 7 Sphynx Analytics Limited, Nicosia 2012, Cyprus 8 Research Group Smart Sensor Systems, The Hague University of Applied Sciences, 2628 AL Delft, The Netherlands 9 Centre for Sustainability, Environment and Health, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands 10 Intracom Telecom, 19002 Peania, Greece 11 Italian National Institute of Health, 00161 Rome, Italy 12 Telecom Italia Spa, 20123 Milan, Italy 13 Department of Applied Physics, The Hebrew University of Jerusalem, Jerusalem 91904, Israel 14 Department of Electrical and Computer Engineering, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel 15 Institut de Ciència de Materials de Barcelona, Consejo Superior de Investigaciones Científicas (ICMAB-CSIC), 08193 Barcelona, Spain 16 Department of Microelectronics, Delft University of Technology, 2628 CN Delft, The Netherlands 17 Sciensano, 1050 Elsene, Belgium 18 Ministry of Health, 28014 Madrid, Spain 19 Dutch Authority for Digital Infrastructure, 9700 AL Groningen, The Netherlands 20 Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany 21 Institute of Veterinary Physiology, University of Zurich, 8006 Zurich, Switzerland
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

NextGEM: Next-generation integrated sensing and analytical system for monitoring and assessing radiofrequency electromagnetic field exposure and health

  • Petroulakis, Nikolaos
  • Soudah, Eduarto
  • Otín, Rubén
The evolution of emerging technologies that use Radio Frequency Electromagnetic Field (RF-EMF) has increased the interest of the scientific community and society regarding the possible adverse effects on human health and the environment. This article provides NextGEM’s vision to assure safety for EU citizens when employing existing and future EMF-based telecommunication technologies. This is accomplished by generating relevant knowledge that ascertains appropriate prevention and control/actuation actions regarding RF-EMF exposure in residential, public, and occupational settings. Fulfilling this vision, NextGEM commits to the need for a healthy living and working environment under safe RF-EMF exposure conditions that can be trusted by people and be in line with the regulations and laws developed by public authorities. NextGEM provides a framework for generating health-relevant scientific knowledge and data on new scenarios of exposure to RF-EMF in multiple frequency bands and developing and validating tools for evidence-based risk assessment. Finally, NextGEM’s Innovation and Knowledge Hub (NIKH) will offer a standardized way for European regulatory authorities and the scientific community to store and assess project outcomes and provide access to findable, accessible, interoperable, and reusable (FAIR) data., This work is part of the European Union’s Horizon Europe research and innovation program under grant agreement No. 101057527 (NextGEM). Funded by the European Union. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. ICMAB-CSIC and CIMNE have also been partially supported by the Spanish Ministry of Science and Innovation, through the Severo Ochoa Programme for Centres of Excellence in R&D (CEX2019–000917-S) and (CEX2018-000797-S), respectively., Peer Reviewed, Article signat per 34 autors/es: Nikolaos Petroulakis 1,* , Mats-Olof Mattsson 2,* , Panos Chatziadam 1 , Myrtill Simko 2 , Andreas Gavrielides 3 , Andrianos M. Yiorkas 3, Olga Zeni 4 , Maria Rosaria Scarfi 4 , Eduardo Soudah 5 , Ruben Otin 5 , Fulvio Schettino 6 , Marco Donald Migliore 6 , Andreas Miaoudakis 7, George Spanoudakis 7 , John Bolte 8,9 , Erdal Korkmaz 8, Vasileios Theodorou 10 , Eleni Zarogianni 10 , Susanna Lagorio 11 , Mauro Biffoni 11 , Andrea Schiavoni 12 , Mauro Renato Boldi 12, Yuri Feldman 13 , Igal Bilik 13,14 , Anna Laromaine 15 , Martí Gich 15 , Marco Spirito 16, Maryse Ledent 17 , Seppe Segers 17 , Francisco Vargas 18, Loek Colussi 19, Mathieu Pruppers 9, Dan Baaken 20 and Anna Bogdanova 21 1 Institute of Computer Science, Foundation for Research and Technology-Hellas (FORTH-ICS), 70013 Heraklion, Greece 2 SciProof International AB, 83158 Ostersund, Sweden 3 eBOS Technologies Limited, Nicosia 2322, Cyprus 4 Institute for Electromagnetic Sensing of the Environment, Consiglio Nazionale delle Ricerche (CNR-IREA), 80124 Napoli, Italy 5 International Centre for Numerical Methods in Engineering (CIMNE), 08034 Barcelona, Spain 6 Department of Electrical and Computer Science Engineering, University of Cassino and Southern Lazio, 03043 Cassino, Italy 7 Sphynx Analytics Limited, Nicosia 2012, Cyprus 8 Research Group Smart Sensor Systems, The Hague University of Applied Sciences, 2628 AL Delft, The Netherlands 9 Centre for Sustainability, Environment and Health, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands 10 Intracom Telecom, 19002 Peania, Greece 11 Italian National Institute of Health, 00161 Rome, Italy 12 Telecom Italia Spa, 20123 Milan, Italy 13 Department of Applied Physics, The Hebrew University of Jerusalem, Jerusalem 91904, Israel 14 Department of Electrical and Computer Engineering, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel 15 Institut de Ciència de Materials de Barcelona, Consejo Superior de Investigaciones Científicas (ICMAB-CSIC), 08193 Barcelona, Spain 16 Department of Microelectronics, Delft University of Technology, 2628 CN Delft, The Netherlands 17 Sciensano, 1050 Elsene, Belgium 18 Ministry of Health, 28014 Madrid, Spain 19 Dutch Authority for Digital Infrastructure, 9700 AL Groningen, The Netherlands 20 Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany 21 Institute of Veterinary Physiology, University of Zurich, 8006 Zurich, Switzerland, Postprint (published version)